Reevaluation of the usefulness of systematic bone scanning in initial staging and follow-up of small cell lung carcinoma, taking into account the serum levels of neuron-specific enolase

International Journal of Biological Markers

Volumn 12, Issue 4, 1997, Pages 148-153

  Gendreau, V ^a   Montravers, F ^a   Philippe, C ^a   Talbot, J N ^a  

^a HÔPITAL TENON   (France)

Author keywords

Follow up; NSE; Small cell lung cancer; Strategy of examinations

Indexed keywords

NEURON SPECIFIC ENOLASE; OXIDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; ENOLASE; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER SCINTISCANNING; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SCINTILLATION CAMERA; BLOOD; BONE; BONE TUMOR; COMPARATIVE STUDY; DIAGNOSTIC TEST; EVALUATION; LUNG TUMOR; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMALL CELL CARCINOMA;

ADULT; AGED; BONE AND BONES; BONE NEOPLASMS; CARCINOMA, SMALL CELL; DIAGNOSTIC TESTS, ROUTINE; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR MARKERS, BIOLOGICAL;

EID: 0031283532     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089701200402     Document Type: Article

References (39)

1. Thurlbeck W, Churg M. Pathology of the lung. New York: Thieme Medical Publishers Inc. Stuttgart: Georg Thieme Verlag, 1995; 790-866.
2. Adewole IF, Newlands ES- Neuron specific enolase as a tumour marker and comparative evaluation with carcinoembryonic antigen in small cell lung cancer. Med Oncol Tumor Pharmacother 1987; 4 (1): 11-5.
3. Akoun GM, Scarna HM, Milleron BJ, Benichou MP, Herman DP. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest 1985; 87 (1): 39-43.
4. Bork E, Hansen M, Urdal P, et al. Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatinine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide. Eur J Cancer Clin Oncol 1988; 24 (6): 1033-8.
5. Buamah PK, Drake SR, Smedley HM, Bodger WA, Skillen AW. Neuron-specific enolase during chemotherapy of small cell lung cancer. J Surg Oncol 1990; 44 (1): 1-4.
6. Burghuber OC, Worofka B, Schernthaner G, et al. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990; 65 (6): 1386-90.
7. Carney DN, Marangos PJ, Ihde DC, et al. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1982; 1 (8272): 583-5.
8. Cooper EH. Neuron-specific enolase (Review). Int J Biol Markers 1994; 9 (4): 205-10.
9. Cooper EH, Splinter TA, Brown DA, Muers MF, Peake MD, Pearson SL. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer 1985; 52 (3): 333-8.
10. Fischbach W, Schwarz-Wallrauch C, Jany B. Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer. Cancer 1989; 63 (6): 1143-9.
11. Gronowitz JS, Bergstrom R, Nou E, et al. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis. Cancer 1990; 66 (4): 722-32.
12. Harding M, McAllister J, Hulks G, et al. Neuron-specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance? Br J Cancer 1990; 61 (4): 605-7.
13. Jacques G, Bepler G, Holle R, et al. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatinine kinase-BB levels in sera of patients with small cell lung cancer. Cancer 1988; 62 (1): 125-34.
14. Johnson PW, Joel SP, Love S, et al. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer. Br J Cancer 1993; 67 (4): 760-6.
15. Johnson DH, Marangos PJ, Forbes JT, et al. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. Cancer Res 1984; 44 (11): 5049-14.
16. Jorgensen LG, Hansen HH, Cooper EH. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur J Cancer Clin Oncol 1989; 25 (1): 123-8.
17. Jorgensen LG, Hirsch FR, Skov BG, Osterlind K, Cooper EH, Larsson LI. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer. Br J Cancer 1991; 63 (1): 151-3.
18. Jorgensen LG, Osterlind K, Hansen HH, Cooper EH. The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer 1988; 58 (6): 805-7.
19. Jorgensen LG, Osterlind K, Hansen HH, Cooper EH. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC). Br J Cancer 1992; 66 (3): 594-8.
20. Jorgensen LG, Osterlind K, Hansen HH, Cooper EH. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC). Br J Cancer 1994; 70 (4): 759-61.
21. Lehtinen M, Wigren T, Lehtinen T, et al. Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer. Tumour Biology 1988; 9 (6): 287-92.
22. Liippo K, Terho T. Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer. Acta Oncologica 1991; 30 (3): 321-4.
23. Nou E, Steinholtz L, Bergh J, Nilsson K, Pahlman S. Neuron-specific enolase, a follow up marker in small cell bronchial carcinoma: a prospective study in an unselected series. Cancer 1990; 65: 1380-5.
24. Quoix E, Charloux A, Popin E, Pauli G. Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer. Eur J Cancer 1993; 29A (16): 2248-50.
25. Rapellino M, Pecchio F, Arosio C, et al. NSE and CEA determination in serum of patients with small cell lung cancer. J Nucl Med Allied Sciences 1990; 34 (4 Suppl): 147-9.
26. Sarandakou A, Poulakis N, Rizos D, Trakakis E, Phocas I. Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma. Anticancer Res 1993; 13 (1): 173-5.
27. Schmechel D, Marangos PJ, Brightman M. Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834-6.
28. Splinter TA, Cooper EH, Kho GS, Oosterom R, Peake MD. Neuron-specific enolase as a guide to the treatment of small eel lung cancer. Eur J Cancer Clin Oncol 1987; 23 (2): 171-6.
29. Splinter TA, Cooper EH, Oosterom R, Peake MD, Brown DA, Kho GS. Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis. Eur J Respiratory Dis 1987; 149: 37-44.
30. Splinter TA, Carney DN, Teeling M, Oosterom R. Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer. J Cancer Res Clin Oncol 1988; 114 (6): 641-3.
31. Splinter TA, Carney DN, Teeling M, et al. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice. J Cancer Res Clin Oncol 1989; 115 (4): 400-1.
32. Tapia FJ, Polak JM, Barbosa AJA, et al. Neuron-specific enolase is produced by neuro-endocrine tumors. Lancet 1981; 1: 808-11.
33. Van de Pol M, Twijnstra A, Ten Velde GP, Menheere PP. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma. J NeuroOncol 1994; 19 (2): 149-54.
34. Van der Gaast A, Van Putten WL, Oosterom R, Cozijnsen M, Hoekstra R, Splinter TA. Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer. Br J Cancer 1991; 64 (2): 369-72.
35. Van Zandwijk N, Jassem E, Bonfrer JM, Van Tinteren H. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma. Eur J Cancer 1990; 26 (3): 373-6.
36. Pinson P, Joos G, Watripont P, Brusselle G, Pauwels R. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer. Respiration 1997; 64 (1): 102-7.
37. Levenson RM Jr, Sauerbrunn BJ, Ihde DC, Bunn PA Jr, Cohen MH, Minna JD. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response. Am J Roentgenol 1981; 137 (1): 31-5.
38. Levitan N, Byrne RE, Bromer RH, et al. The value of the bone scan and bone marrow biopsy in staging small cell lung cancer. Cancer 1985; 56 (3): 652-4.
39. Resche I, Buhe T, Roge C, Bizais Y. Comparison of bone scintigram, MRI and osteomedullar biopsy in the detection of bone metastases in small cell lung cancer. J Nucl Med 1992; 32: 962.